To the best of our knowledge, this was the first Indonesian study that evaluated the presence of SARS-CoV-2 IgM and/or IgG antibodies in a high number of dengue-confirmed samples predating the COVID-19 pandemic-with the primary objective of confirming the cross-reactivity. Here, CD40LG is linked to dengue disease.